Treace Medical Concepts IncTMCI
Price$4.44

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value not published yet, our data-reliability standards weren't met; method estimates belowbased on filings through 30 Jun 2026
Market Price $4.44Price as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 10.3%/yr (balance of the path).9.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 610.1%Yr 79.9%Yr 89.7%Yr 99.5%Yr 109.3%
10.3% → 9.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.6%Yr 128.0%Yr 137.4%Yr 146.8%Yr 156.1%Yr 165.5%Yr 174.9%Yr 184.3%Yr 193.6%Yr 203.0%
9.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 10.6%
Volatility vs market (adjusted beta)1.27

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetTreace Medical Concepts IncTMCIHealth Care
Valuation
P/E—
P/S1.4×
P/B4.3×
EV / Revenue1.7×
EV / EBITDA—
Profitability
Gross margin79.3%
Operating margin-36.4%
Net margin-29.0%
FCF margin-12.2%
Returns
ROE-87.9%
ROA-32.9%
ROIC—
Growth
Revenue growth (YoY)-1.9%
5-yr fwd EPS growth9.3%
Financial strength
Debt / Equity0.87×
Current ratio2.90×
Altman Z-Score0.1
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.